Impact of multiple sclerosis relapses on progression diminishes with time (Q33898204)

29 July 2017

Impact of multiple sclerosis relapses on progression diminishes with time (English)

1 reference

29 July 2017

0 references

H Tremlett

1

1 reference

29 July 2017

M Yousefi

2

1 reference

29 July 2017

V Devonshire

3

1 reference

29 July 2017

P Rieckmann

4

1 reference

29 July 2017

Y Zhao

5

1 reference

29 July 2017

UBC Neurologists

6

1 reference

29 July 2017

language of work or name

English

0 references

publication date

4 November 2009

1 reference

29 July 2017

1 reference

29 July 2017

73

1 reference

29 July 2017

20

1 reference

29 July 2017

1616-1623

1 reference

Does the season or month of birth influence disease progression in multiple sclerosis?

29 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2881858

Effect of relapses on development of residual deficit in multiple sclerosis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2881858

Prognostic factors for progression of disability in the secondary progressive phase of multiple sclerosis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2881858

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2881858

Survival probabilities (the Kaplan-Meier method).

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2881858

Survival and predictors of disability in Turkish MS patients. Turkish Multiple Sclerosis Study Group (TUMSSG).

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2881858

Defining the clinical course of multiple sclerosis: Results of an international survey

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2881858

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2881858

Prevalence of multiple sclerosis in British Columbia

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2881858

Interrater variability with the Expanded Disability Status Scale (EDSS) and Functional Systems (FS) in a multiple sclerosis clinical trial. The Canadian Cooperation MS Study Group.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2881858

The natural history of multiple sclerosis: a geographically based study. 3. Multivariate analysis of predictive factors and models of outcome.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2881858

Early prognostic factors for disability in multiple sclerosis, a European multicenter study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2881858

Is late-onset multiple sclerosis associated with a worse outcome?

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2881858

Disability progression in multiple sclerosis is slower than previously reported.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2881858

The natural history of primary progressive MS in British Columbia, Canada.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2881858

The window of therapeutic opportunity in multiple sclerosis: evidence from monoclonal antibody therapy.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2881858

Long-term follow up of patients with clinically isolated syndromes, relapsing-remitting and secondary progressive multiple sclerosis.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2881858

Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2881858

Enhancement frequency decreases with increasing age in relapsing-remitting multiple sclerosis.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2881858

Axon loss in multiple sclerosis.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2881858

Course of multiple sclerosis. First results of a prospective study carried out of 102 MS patients from 1976-1980.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2881858

Relapses and progression of disability in multiple sclerosis

29 October 2018

1 reference

12 December 2020

Randomized controlled trial of interferon- beta-1a in secondary progressive MS: Clinical results

1 reference

12 December 2020

Chemokine-based therapies for MS: how do we get there from here?

1 reference

12 December 2020

Contribution of relapses to disability in multiple sclerosis

1 reference

12 December 2020

Natural history of secondary-progressive multiple sclerosis

1 reference

12 December 2020

Relapses in multiple sclerosis are age- and time-dependent

1 reference

12 December 2020

Natural history comparisons of primary and secondary progressive multiple sclerosis reveals differences and similarities

1 reference

12 December 2020

The course of multiple sclerosis in 73 cases with computer-designed curves

1 reference

12 December 2020

Studies on the natural history of multiple sclerosis--8. Early prognostic features of the later course of the illness

1 reference

12 December 2020

The natural history of multiple sclerosis: a geographically based study. 2. Predictive value of the early clinical course

1 reference

12 December 2020

Life expectancy in patients attending multiple sclerosis clinics

1 reference

12 December 2020

Demyelinating diseases--new pathological insights, new therapeutic targets

1 reference

12 December 2020

10.1212/WNL.0B013E3181C1E44F

Identifiers

DOI

1 reference

29 July 2017

1 reference

29 July 2017

1 reference